News
XenoTech Receives New US Patent for a Method to Evaluate Xenobiotics as Immune-Modulators of Drug Transport and Metabolism in Hepatocytes
Kansas City, KS– XenoTech has been awarded US patent # 10,648,968 “In vitro test system to evaluate xenobiotics as immune-modulators...
XenoTech Expands Access to Top-Tier DDI Expertise & Consultancy
Kansas City, KS – XenoTech is expanding opportunities for clients to work with top-tier consultants to evaluate drug-drug interaction potential...
New Head of KC-Based Drug Development CRO Poised for Further Growth and Expansion
XenoTech announces the promotion of Dr. Darren Warren to President and Chief Executive Officer...
XenoTech Announces Expanded Consulting Opportunities Available to Clients
Kansas City, KS- XenoTech now provides the opportunity for clients to work with top-tier consultants to analyze critical components of...
XenoTech Announces Enhanced Synergy in ADME Testing Services
Kansas City, KS– XenoTech is collaborating with the Drug Development Solutions Center to offer a full suite of nonclinical testing services specializing in the...
XenoTech Celebrates 25th Anniversary
In 2019, XenoTech celebrated its 25th birthday, and our Japan branch from when we were part of SEKISUI turned 64!...
XenoTech Achieves Record Revenue and Employment Numbers
Kansas City, KS – XenoTech will celebrate its 25th anniversary this November, coming into the year with record-breaking achievements. Expansions reflect growth in...
XenoTech Announces Creation of Scientific Advisory Board (SAB)
Kansas City, KS- XenoTech has created a Scientific Advisory Board (SAB) of renowned scientists and thought leaders in the pharmaceutical industry. Initially this...
XenoTech Adds Monkey, Rodent Hepatocytes to Patented CryostaX Product Line
Company Anticipates the End of Traditionally Cryopreserved Hepatocytes Kansas City, KS- XenoTech is expanding its catalog of CryostaX® in vitro drug discovery and...
XenoTech Receives New US Patent for Evaluating Xenobiotic Drug Metabolism in Hepatocytes
Kansas City, KS- XenoTech has been awarded US patent #10,001,471 “In vitro test system to evaluate xenobiotics as immune-modulators of drug transport and metabolism in human hepatocytes.” In...